MT1G and nonpapillary renal cell carcinoma: Above results revealed that MT1G overexpression increased the subcutaneous tumorigenic capacity of ccRCC 786-O cells compared to the control group, resulting in more tumors (Fig. 2a), increased tumor weight (Fig. 2b), and larger tumor volumes (Fig. 2c).